Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Biomolecular Detection and Quantification
|
March 24, 2017
Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
Mary Alikian, Robert Peter Gale, Jane F Apperley, et al.
Leukemia Research
|
August 24, 2016
Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia
Gareth Gerrard, Hui En Foong, Katherine Mudge, et al.
British Journal of Haematology
|
April 19, 2017
Mutational landscape of B-cell post-transplant lymphoproliferative disorders
Thomas Menter, Darius Juskevicius, Mary Alikian, et al.
American Journal of Hematology
|
May 9, 2012
Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonization
Gareth Gerrard, Katherine Mudge, Pierre Foskett, et al.
British Journal of Haematology
|
April 14, 2019
Impaired cellular and humoral immunity is a feature of Diamond-Blackfan anaemia; experience of 107 unselected cases in the United Kingdom
Deena Iskander, Irene Roberts, Clare Rees, et al.
International Journal of Molecular Sciences
|
May 3, 2016
Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches
Sandra Preuner, Agnes Barna, Florian Frommlet, et al.
American Journal of Hematology
|
September 25, 2014
PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase
Juan M Alonso-Dominguez, Jacob Grinfeld, Mary Alikian, et al.
Clinical Chemistry
|
December 17, 2016
RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia
Mary Alikian, Alexandra S Whale, Susanna Akiki, et al.
The Journal of Molecular Diagnostics : JMD
|
February 10, 2016
Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients
Mary Alikian, Peter Ellery, Martin Forbes, et al.
American Journal of Hematology
|
January 11, 2012
BCR-ABL1 kinase domain mutations: methodology and clinical evaluation
Mary Alikian, Gareth Gerrard, Papagudi G Subramanian, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Biomolecular Detection and Quantification
|
March 24, 2017
Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
Mary Alikian, Robert Peter Gale, Jane F Apperley, et al.
Leukemia Research
|
August 24, 2016
Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia
Gareth Gerrard, Hui En Foong, Katherine Mudge, et al.
British Journal of Haematology
|
April 19, 2017
Mutational landscape of B-cell post-transplant lymphoproliferative disorders
Thomas Menter, Darius Juskevicius, Mary Alikian, et al.
American Journal of Hematology
|
May 9, 2012
Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonization
Gareth Gerrard, Katherine Mudge, Pierre Foskett, et al.
British Journal of Haematology
|
April 14, 2019
Impaired cellular and humoral immunity is a feature of Diamond-Blackfan anaemia; experience of 107 unselected cases in the United Kingdom
Deena Iskander, Irene Roberts, Clare Rees, et al.
International Journal of Molecular Sciences
|
May 3, 2016
Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches
Sandra Preuner, Agnes Barna, Florian Frommlet, et al.
American Journal of Hematology
|
September 25, 2014
PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase
Juan M Alonso-Dominguez, Jacob Grinfeld, Mary Alikian, et al.
Clinical Chemistry
|
December 17, 2016
RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia
Mary Alikian, Alexandra S Whale, Susanna Akiki, et al.
The Journal of Molecular Diagnostics : JMD
|
February 10, 2016
Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients
Mary Alikian, Peter Ellery, Martin Forbes, et al.
American Journal of Hematology
|
January 11, 2012
BCR-ABL1 kinase domain mutations: methodology and clinical evaluation
Mary Alikian, Gareth Gerrard, Papagudi G Subramanian, et al.
Page
of 2